ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Novel nanomedicines to overcome cancer multidrug resistance

Su, Zhenwei; Dong, Shaowei; Zhao, Shan-Chao; Liu, Kaisheng; Tan, Yao; Jiang, Xingyu; Assaraf, Yehuda G.; Qin, Bo*; Chen, Zhe-Sheng*; Zou, Chang*南方医科大学; 1
DRUG RESISTANCE UPDATES2021-9DOI: 10.1016/j.drup.2021.100777
89被引13阅读
引用收藏
分享

摘要

Chemotherapy remains a powerful tool to eliminate malignant cells. However, the efficacy of chemotherapy is compromised by the frequent emergence of intrinsic and acquired multidrug resistance (MDR). These chemoresistance modalities are based on a multiplicity of molecular mechanisms of drug resistance, including : 1) Impaired drug uptake into cancer cells; 2) Increased expression of ATP-binding cassette efflux transporters; 3) Loss of function of pro-apoptotic factors; 4) Enhanced DNA repair capacity; 5) Qualitative or quantitative alterations of specific cellular targets; 6) Alterations that allow cancer cells to tolerate adverse or stressful conditions; 7) Increased biotransformation or metabolism of anticancer drugs to less active or completely inactive metabolites; and 8) Intracellular and intercellular drug sequestration in well-defined organelles away from the cellular target. Hence, one of the major aims of cancer research is to develop novel strategies to overcome cancer drug resistance. Over the last decades, nanomedicine, which focuses on targeted delivery of therapeutic drugs into tumor tissues using nano-sized formulations, has emerged as a promising tool for cancer treatment. Therefore, nanomedicine has been introduced as a reliable approach to improve treatment efficacy and minimize detrimental adverse effects as well as overcome cancer drug resistance. With rationally designed strategies including passively targeted delivery, actively targeted delivery, delivery of multidrug combinations, as well as multimodal combination therapy, nanomedicine paves the way towards efficacious cancer treatment and hold great promise in overcoming cancer drug resistance. Herein, we review the recent progress of nanomaterials used in medicine, including liposomal nanoparticles, polymeric nanoparticles, inorganic nanoparticles and hybrid nanoparticles, to surmount cancer multidrug resistance. Finally, the future perspectives of the application of nanomedicine to reverse cancer drug resistance will be addressed.

学科与关键词

关键词
CancerAntitumor drugsDrug resistanceMDRP-gpABCB1Nanomedicine
相关
加载中…
  • Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy
    Cao, Lei; Zhu, Yuqin; Wang, Weiju; Wang, Gaoxiong*; Zhang, Shuaishuai*; Cheng, Hongwei*Frontiers in Bioengineering and Biotechnology, 2021, 9: 798882.被引 19
  • Self-delivery nanomedicine to overcome drug resistance for synergistic chemotherapy?
    Zheng, Rong-Rong; Zhao, Lin-Ping; Liu, Ling-Shan; Deng, Fu-An; Chen, Xia-Yun; Jiang, Xue-Yan; Wang, Chang; Yu, Xi-Yong*; Cheng, Hong*; Li, Shi-Ying*Biomaterials Science, 2021, 9(9): 3445-3452.被引 18
  • Editorial: Novel Small-Molecule Agents in Overcoming Multidrug Resistance in Cancers
    Cui, Qingbin*; Wang, Cong; Zeng, Leli; Zhou, Qian-Xiong; Fan, Ying-FangFrontiers in Chemistry, 2022, 10: 921985.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
DRUG RESISTANCE UPDATES
发表日期
2021-09
卷期
第 58 卷
页码
100777
DOI
10.1016/j.drup.2021.100777
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
Guangdong Basic and Applied Basic Research Foundation [2020B1515120032]; Guang-dong Basic and Applied Basic Research fund project [2019B1515120033]; Science and Technology Foundation of Shenzhen [JCYJ20180305164128430]; International Cooperation Foundation of Shenzhen [GJHZ20180928171602104]; Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis; Shenzhen Economic and Information Committee "Innovation Chain and Industry Chain" integration special support plan project [20180225112449943]; Shenzhen Key Medical Discipline Construction Fund [SZXK053]

作者

  • S

    Su, Zhenwei (第一作者)

    2 · 1

  • D

    Dong, Shaowei

    1 · 2

查看全部 10 位作者收起作者
  • Z

    Zhao, Shan-Chao

    southern med univ

  • L

    Liu, Kaisheng

    2 · 1

  • T

    Tan, Yao

  • J

    Jiang, Xingyu

  • A

    Assaraf, Yehuda G.

  • Q

    Qin, Bo (通讯)

  • C

    Chen, Zhe-Sheng (通讯)

  • Z

    Zou, Chang (通讯)

    2 · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417